Invitro studies and evaluation of metformin marketed tablets-Malaysia
Arcot Ravindran Chandrasekaran, Chan Yoke Jia, Choong Sheau Theng, Teeba Muniandy, Selvadurai Muralidharan, Sokkalingam Arumugam Dhanaraj
Pages: 214-217
Post market Research of Oral Anti-Diabetic Drugs: Metformin, Glipizide, and Pioglitazone
Nabil Khalidi, Bassam Atallah, Abdulmalik M. Alkatheri, Abdulkareem Albekairy, Amjad M. Qandil
DOI: 10.7324/JAPS.2014.40609Pages: 061-067
In vitro Cytotoxicity and Glucose Uptake Activity of Fruits of Terminalia bellirica in Vero, L-6 and 3T3 cell lines
Mary Shoba Das, Gayathri Devi
DOI: 10.7324/JAPS.2015.501215Pages: 092-095
Analytical method development and validation for simultaneous estimation of Teneligliptin hydrobromide hydrate and Metformin hydrochloride from it’s pharmaceutical dosage form by three different UV spectrophotometric methods
Ashim Kumar Sen, Denish N. Hinsu, Dhanya B. Sen, Aarti S. Zanwar, Rajesh A. Maheshwari, Vikas R. Chandrakar
DOI: 10.7324/JAPS.2016.60924Pages: 157-165
Application of simplex centroid design in formulation and optimization of floating matrix tablets of metformin
Meenakshi Bhavesh Patel, Farhatjahan Shaikh, Vandana Patel, Naazneen Imtiaz Surti
DOI: 10.7324/JAPS.2017.70403Pages: 023-030
Simultaneous quantification of ramipril, glimepiride and metformin in human plasma by ultra-performance liquid chromatography – tandem mass spectrometry
Eman S. Elzanfaly, Sherif A. Abdel-Gawad
DOI: 10.7324/JAPS.2017.70711Pages: 062-069
Prescribing Pattern of Gliclazide, Metformin and Combination Therapy with Insulin in UAE
Sabrina Ait Gacem, Zainab Tehami, Maryam Mazrouai, Mohamed Shamssain
DOI: 10.7324/JAPS.2018.8623Pages: 175-177
Diabetes induced internal organs inflammation in non-obese type 2 diabetic rats
Podsawee Mongkolpathumrat, Nuttikarn Nokkaew, Punyanuch Adulyaritthikul, Kantapich Kongpol, Jantira Sanit, Panyupa Pankhong, Sarawut Kumphune
DOI: 10.7324/JAPS.2019.90307Pages: 041-049
Anti-diabetic drug, metformin, and the p38 inhibitor (SB203580) reduces internal organs oxidative stress in non-obese type 2 diabetic rats
Nuttikarn Nokkaew, Jantira Sanit, Podsawee Mongkolpathumrat, Siyamon Boontawee, Supanut Ithipruchyabun, Wannapa Plangklang, Punyanuch Adulyaritthikul, Kantapich Kongpol, Sarawut Kumphune
DOI: 10.7324/JAPS.2019.90502Pages: 012-020
The effect of metformin and P38 MAPK inhibitor on diabetic bone porosity in non-obese type 2 diabetic rats
Punyanuch Adulyaritthikul, Jantira Sanit, Nuttikarn Nokkaew, Kantapich Kongpol, Podsawee Mongkolpathumrat, Sakarat na Lampang, Catleya Rojviriya, Sarawut Kumphune
DOI: 10.7324/JAPS.2019.90711Pages: 082-090
Formulation and stability studies of metformin hydrochloride in a controlled porosity osmotic pump system
Hanan M. Hashem, Aya R. Abdou, Nesrin F. Taha, Nadia M. Mursi, Laila H. Emara
DOI: 10.7324/JAPS.2020.104013Pages: 100-112
Strong cation exchange chromatography: a new option for concurrent quantification of saxagliptin and metformin
Pankaj Manohar Kharabe, Deepali Kailas Kadam
DOI: 10.7324/JAPS.2021.110913Pages: 110-117
Effect of metformin treatment on inflammatory markers in type 2 diabetes mellitus—A systematic review and meta-analysis
Renuka Suvarna, Revathi P. Shenoy, M. Mukhyaprana Prabhu, Guruprasad Kalthur, Basavaraj S. Hadapad, Varashree Bolar Suryakanth
DOI: 10.7324/JAPS.2022.120401Pages: 001-011
